Abstract OT2-07-01: A phase 2 study of futibatinib (TAS-120) in metastatic breast cancers harboring fibroblast growth factor receptor (FGFR) amplifications (FOENIX-MBC2)
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institutions: Institute of Cancer Research, Royal Marsden Hospital, Dana-Farber Cancer Institute, Harvard University, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, Universidad Complutense de Madrid, GEICAM – Spanish Breast Cancer Group, Taiho Oncology (United States), Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3006072778